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Retinopathy of Prematurity (ROP) is a disorder of altered retinal
vasculature occurring in low birthweight infants (1250 grams or
less). These vascular abnormalities evolve over time and may
progress through stages. ROP may result in permanent visual
disability or blindness.1
The Committee for the Classification of ROP identified the five
basic stages ofvascular and retinal abnormalities.2Embryologically
the retinal vasculature begins at the optic nerve and grows anteriorly
in the retina toward the ora serrata, the anterior insertion of the
retina. The geographic growth of the retinal vasculature is divided
into Zones. Zone 1 is twice the distance of the radius beginning from
the optic nerve extending to the macula. Zone 2 is the radius from
the optic nerve extending to the nasal ora serrata. Zone 3 extends
from the anterior border temporally of Zone 2 to the temporal ora
serrata. The vascular abnormalities are classified by Stages. Stage
1 ROP shows terminal vascular arborization with a terminal line
(whitish-gray thread-like line) separating vascularized from avas
cular retina. In Stage 2 ROP the line becomes a ridge with definite
thickness and broadness. In Stage 3 there is fibrovascular prolifera
tion along the surface of the retina and into the vitreous. If the vessels
exiting the optic nerve are tortuous and dilated this is known as
“Plus” Disease. Stage 4a is partial retinal detachment not involving
the macula whereas Stage 4b involves the macula. Stage 5 is total
retinal detachment of the vascularized retina. This results in a
funnel-shaped detachment.3Of premature infants weighing less
than 1250 gmat birth 25.2% develop Stage 1. 21.7% develop Stage
2, and 18.3% develop Stage 34 “Plus” disease can progress through
Stage 1 and 2 quickly thus necessitating frequent ocular exams in the
neonatal ICU. Although most ROP regresses, it can exacerbate thus
requiring continued monitoring until full vascularization of the
retina.
The Japanese report on regression of ROP following ablation of
the peripheral avascular retina prompted a prospective randomized
clinical trial comparing observation alone to cryoablation.56The
eyes reaching Threshold for surgery had “Plus” disease with five
continuous hours or eight total clock hours with Stage 3 in Zone 1
or2. The operated eyes had a 31.1% unfavorable result compared to
5 1.4% in the control group.
With the advent of better laser surgery delivery systems, it became
possible to ablate the peripheral avascular retina with laser surgery.
A prospective randomized study was not feasible. The Laser-ROP
Study Group combined three large laser studies and determined
equal efficacy to cryosurgery.7There is indication that laser surgery
for Threshold Disease in Zone 1 may have better result than
cryosurgery. Laser surgery carries significantly less morbidity than
cryosurgery. Hawaii has had laser capability for ROP disease for
some time. This significantly reduces the risk of Threshold ROP
progressing to retinal detachment.
Those eyes progressing to retinal detachment can be operated with
scleral buckle operation. Scleral buckle reduces progression from
Stage 4 to Stage 5 ROP. Vitrectomy surgery can help in severe
Stage 5 ROP although the visual result has not been very gratifying.
Much work needs to be done to obtain better vision results in these
advanced cases and to prevent progression to this level..
With new technical and pharmacological advances the low
birthweight infant is increasingly surviving and we need to be
watchful for the incidence of ROP is increasing.9Newer research
initiatives continue to look for ways to prevent or resolve ROP to
reduce vision loss. Animal studies show that too much oxygen given
shortly after birth causes ROP.’° However, animal studies also
demonstrate that too little oxygen later can make ROP worse if it
already exists.” The STOP-ROP Study (Supplemental Therapeutic
Oxygen for Prethreshold), funded by the NIH, is registering infants
with marginal arterial oxygenation and “Prethreshold” ROP dis
ease. Kapiolani Medical Center for Women and Children is one of
the clinical trial centers. This study will determine if supplemental
oxygen will reduce the number of infant eyes progressing to
Threshold ROP. STOP-ROP is also examining the effects of supple
mental oxygen on infant growth rate, pulmonary disease, and length
of stay. Hopefully, this study will definitively answer the question
as to the role of Oxygen administration in the development of ROP.
Retinopathy of Prematurity requires ongoing research to deter
mine its multifactorial causes and the best ways to prevent and halt
its potentially devastating end result of blindness.
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